Skip to content

Investigating the sedative effect of Melatonin in Cataract surgery

Investigating the effect of oral Melatonin premedication on the quality of sedation and pain scale in Cataract surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160307026950N45
Enrollment
40
Registered
2022-09-10
Start date
2022-09-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Age-related cataract

Interventions

Intervention 1: Intervention group: In this group, patients receive a sublingual tablet containing 3 mg of Melatonin manufactured by Norm Life 1 hour before surgery. After being placed on the surgical

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 ASA class I, II and III Candidate for Cataract surgery Informed consent for study

Exclusion criteria

Exclusion criteria: Patients with a history of obstructive sleep apnea Patients treated with psychiatric drugs Patients with autoimmune diseases, diabetes, nystagmus, leukemia and deafness Allergy to the drugs used Use of painkillers in the past week BMI index greater than 35

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: before the intervention, before the operation, after anesthesia and then every 10 minutes until the end of recovery. Method of measurement: Behavioral Pain Scale questionnaire.

Secondary

MeasureTime frame
Heart Rate. Timepoint: before the intervention, before the operation, after anesthesia and then every 10 minutes until the end of recovery. Method of measurement: ECG monitoring.;Blood Pressure. Timepoint: before the intervention, before the operation, after anesthesia and then every 10 minutes until the end of recovery. Method of measurement: Sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Andalib

Esfahan University of Medical Sciences

Andalibshahrzad@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026